Variant report
Variant | esv3345362 |
---|---|
Chromosome Location | chr8:126489195-126491743 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:15)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:15 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:126487669..126490463-chr8:126500662..126505453,4 | MCF-7 | breast: | |
2 | chr8:126444118..126444925-chr8:126489102..126489871,3 | MCF-7 | breast: | |
3 | chr8:126440590..126444026-chr8:126489711..126492773,5 | K562 | blood: | |
4 | chr8:126487883..126490527-chr8:126491210..126493645,2 | K562 | blood: | |
5 | chr8:126487883..126490527-chr8:126491210..126493645,2 | K562 | blood: | |
6 | chr8:126487201..126489383-chr8:126491210..126493652,2 | K562 | blood: | |
7 | chr8:126490852..126493614-chr8:126495231..126496917,2 | K562 | blood: | |
8 | chr8:126488519..126490566-chr8:126531807..126533427,2 | MCF-7 | breast: | |
9 | chr8:126441090..126444547-chr8:126489407..126493139,4 | MCF-7 | breast: | |
10 | chr8:126481379..126484101-chr8:126487149..126489863,2 | MCF-7 | breast: | |
11 | chr8:126490839..126493464-chr8:126493478..126495853,2 | MCF-7 | breast: | |
12 | chr8:126440471..126443261-chr8:126490513..126492965,2 | K562 | blood: | |
13 | chr8:126441723..126444081-chr8:126487390..126489417,3 | MCF-7 | breast: | |
14 | chr8:126488058..126489576-chr8:126500538..126503490,2 | MCF-7 | breast: | |
15 | chr8:126487201..126489383-chr8:126491210..126493652,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000173334 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534962723 | chr8:126489204-126489205 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs71516787 | chr8:126489216-126489217 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs190639596 | chr8:126489236-126489237 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs61002144 | chr8:126489248-126489249 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs141908735 | chr8:126489281-126489282 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs549294811 | chr8:126489326-126489327 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs556590673 | chr8:126489357-126489358 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs185630442 | chr8:126489459-126489460 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs576459995 | chr8:126489461-126489462 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs567117760 | chr8:126489474-126489475 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs539016241 | chr8:126489478-126489479 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs376392810 | chr8:126489500-126489501 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs114137580 | chr8:126489511-126489512 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs72655687 | chr8:126489528-126489529 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs150836951 | chr8:126489558-126489559 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs183460653 | chr8:126489608-126489609 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs372638967 | chr8:126489622-126489623 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs561262653 | chr8:126489623-126489624 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs574664552 | chr8:126489701-126489702 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs139363753 | chr8:126489809-126489810 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs397893053 | chr8:126489814-126489815 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs372163477 | chr8:126489815-126489816 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs67346026 | chr8:126489818-126489819 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs370852214 | chr8:126489822-126489823 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs532505557 | chr8:126489832-126489833 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs534636518 | chr8:126489857-126489858 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs56272180 | chr8:126489860-126489861 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs71295861 | chr8:126489861-126489862 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs116866186 | chr8:126489878-126489879 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs559417733 | chr8:126489941-126489942 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs71576789 | chr8:126490022-126490023 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs58346265 | chr8:126490038-126490039 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs186311403 | chr8:126490111-126490112 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs374621517 | chr8:126490179-126490180 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs548468877 | chr8:126490183-126490184 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs568383499 | chr8:126490222-126490223 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs56991585 | chr8:126490264-126490265 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs373832648 | chr8:126490291-126490292 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs28788330 | chr8:126490298-126490299 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs28778891 | chr8:126490301-126490302 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs28820427 | chr8:126490307-126490308 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs60681360 | chr8:126490352-126490353 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs59841811 | chr8:126490368-126490369 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs58271893 | chr8:126490379-126490380 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs60537876 | chr8:126490382-126490383 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs183206591 | chr8:126490426-126490427 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs550545312 | chr8:126490441-126490442 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs373559980 | chr8:126490453-126490454 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs570134335 | chr8:126490470-126490471 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs71576790 | chr8:126490479-126490480 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 20932292 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 22056952 | CNVD |
Langer-Giedion syndrome | 16773131 | CNVD |
Lung cancer | 16740712 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Langer-Giedion syndrome | 22470819 | CNVD |
Cornelia de Lange syndrome | 24599119 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 16397240 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Breast cancer | 21364760 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21611746 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Gastric cancer | 18160780 | CNVD |
Gastric cancer | 21635755 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:126479400-126489200 | Weak transcription | Pancreas | Pancrea |
2 | chr8:126483000-126489400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr8:126483000-126498200 | Weak transcription | Right Atrium | heart |
4 | chr8:126483200-126489400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr8:126483400-126496600 | Weak transcription | Hela-S3 | cervix |
6 | chr8:126487000-126490000 | Enhancers | Placenta | Placenta |
7 | chr8:126487200-126492400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr8:126487400-126489600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr8:126487600-126491800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr8:126487600-126492000 | Weak transcription | NHEK | skin |
11 | chr8:126487600-126493200 | Weak transcription | HMEC | breast |
12 | chr8:126487600-126496600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr8:126488000-126489200 | Weak transcription | Placenta Amnion | Placenta Amnion |
14 | chr8:126488000-126497200 | Weak transcription | Liver | Liver |
15 | chr8:126489000-126489600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr8:126489000-126489600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr8:126489000-126489600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr8:126489200-126489400 | Enhancers | Pancreas | Pancrea |
19 | chr8:126489200-126489600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
20 | chr8:126489200-126489600 | Enhancers | Placenta Amnion | Placenta Amnion |
21 | chr8:126489400-126489600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
22 | chr8:126489400-126489800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
23 | chr8:126489600-126493400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
24 | chr8:126489800-126491400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
25 | chr8:126491400-126492000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
26 | chr8:126491400-126492000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
27 | chr8:126491600-126491800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
28 | chr8:126491600-126493600 | Enhancers | Primary neutrophils fromperipheralblood | blood |